A new MRI marker of ataxia with oculomotor apraxia.

Solène Ronsin, Salem Hannoun, Stéphane Thobois, Philippe Petiot, Alain Vighetto, François Cotton, Caroline Tilikete

Journal: European journal of radiology 2019;110():187-192

PMID: 30599859

Abstract

PURPOSE

Evaluate the specificity and sensitivity of disappearance of susceptibility weighted imaging (SWI) dentate nuclei (DN) hypointensity in oculomotor apraxia patients (AOA).

METHOD

In this prospective study, 27 patients with autosomal genetic ataxia (AOA (n = 11), Friedreich ataxia and ataxia with vitamin E deficit (n = 4), and dominant genetic ataxia (n = 12)) were included along with fifteen healthy controls. MRIs were qualitatively classified for the presence or absence of DN hypointensity on FLAIR and SWI sequences. The MRIs were then quantitatively studied, with measurement of a ratio of DN over brainstem white matter signal intensity through manual delineation. The institutional review board approved this study, and written informed consent was obtained. In the cross-sectional analysis, the Mann-Whitney test was applied.

RESULTS

Qualitatively, the eleven AOA patients presented absence of both DN SWI and FLAIR hyposignals; three dominant genetic ataxia patients had moderate SWI DN hyposignal and absent FLAIR hyposignal; the thirteen remaining subjects presented normal SWI and FLAIR DN hyposignal. Absence of DN SWI hypointensity was 100% sensitive and specific to AOA. Quantitative signal intensity ratio (mean ± standard deviation) of the AOA group (98·96 ± 5·37%) was significantly higher than in control subjects group (76.40 ± 8.34%; p < 0.001), dominant genetic ataxia group (81·15 ± 9·94%; p < 0·001), and Friedreich ataxia and ataxia with vitamin E deficit group (87·56 ± 2·78%; p < 0·02).

CONCLUSION

This small study shows that loss of the normal hypointensity in the dentate nucleus on both SWI and FLAIR imaging at 3 T is a highly sensitive and specific biomarker for AOA.

Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Address: Hospices Civils de Lyon, Neurology D and Neuro-Ophthalmology Unit, Hôpital Neurologique Pierre Wertheimer, Bron, F-69677, France; Université de Lyon, Lyon 1 University, Lyon, F-69373, France.; CREATIS, INSERM U1206 & CNRS UMR 5220, Lyon, F-69000, France; Nehme and Therese Tohme Multiple Sclerosis Center, Faculty of Medicine, American University of Beirut, Beirut, 1107 2020, Lebanon.; Université de Lyon, Lyon 1 University, Lyon, F-69373, France; Hospices Civils de Lyon, Neurology C, Hôpital Neurologique Pierre Wertheimer, Bron, F-69677, France; Centre de Neurosciences Cognitives de Lyon, CNRS UMR 5229, Bron F-69500, France.; Hospices Civils de Lyon, Explorations Fonctionnelles Neurologiques, Hôpital de la Croix Rousse, Lyon, F-69004, France.; Hospices Civils de Lyon, Neurology D and Neuro-Ophthalmology Unit, Hôpital Neurologique Pierre Wertheimer, Bron, F-69677, France; Université de Lyon, Lyon 1 University, Lyon, F-69373, France; Lyon Neuroscience Research Center, INSERM U1028 CNRS UMR5292, Team ImpAct, Bron, F-69676, France.; Université de Lyon, Lyon 1 University, Lyon, F-69373, France; CREATIS, INSERM U1206 & CNRS UMR 5220, Lyon, F-69000, France; Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service de Radiologie and Laboratoire d'Anatomie de Rockefeller, Lyon, F-69000, France. Electronic address: [email protected].; Hospices Civils de Lyon, Neurology D and Neuro-Ophthalmology Unit, Hôpital Neurologique Pierre Wertheimer, Bron, F-69677, France; Université de Lyon, Lyon 1 University, Lyon, F-69373, France; Lyon Neuroscience Research Center, INSERM U1028 CNRS UMR5292, Team ImpAct, Bron, F-69676, France. Electronic address: [email protected].

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.